Cargando…
The safety profile of COVID-19 vaccinations in the United States
BACKGROUND/AIM: Pfizer-BioNTech, Moderna, and Johnson & Johnson's Janssen are the 3 COVID-19 vaccines authorized for emergency use in the United States. This study aims to analyze and compare adverse events following immunization associated with these COVID-19 vaccines based on Vaccine Adve...
Autores principales: | Singh, Amninder, Khillan, Ratesh, Mishra, Yogendra, Khurana, Sumit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539830/ https://www.ncbi.nlm.nih.gov/pubmed/34699960 http://dx.doi.org/10.1016/j.ajic.2021.10.015 |
Ejemplares similares
-
COVID-19 Mitigation With Appropriate Safety Measures in an Essential Workplace: Lessons for Opening Work Settings in the United States During COVID-19
por: Haigh, Karen Z, et al.
Publicado: (2021) -
Symptoms of COVID-19 Outpatients in the United States
por: Pullen, Matthew F, et al.
Publicado: (2020) -
The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States
por: Moghadas, Seyed M, et al.
Publicado: (2021) -
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
por: Lewis, Nathaniel M, et al.
Publicado: (2022) -
A Case of Long-term Survival of 36 Months in the Setting of Extensive-disease Small-cell Lung Cancer
por: Ramineni, Gowthami, et al.
Publicado: (2019)